Leon M. T. Dicks, Shelly M. Deane & Matthew J. GrobbelaarÂ
doi : 10.1007/s12602-022-09925-5
The microfilaricidal anthelmintic drug ivermectin (IVM) has been used since 1988 for treatment of parasitic infections in animals and humans.
Abdolamir Ghadaksaz, Somayeh Mousavi Nodoushan, Hamid Sedighian, Elham Behzadi & Abbas Ali Imani FooladiÂ
doi : 10.1007/s12602-021-09893-2
Probiotics are living microorganisms that have favorable effects on human and animal health. The most usual types of microorganisms recruited as probiotics are lactic acid bacteria (LAB) and bifidobacteria.
Lorena Trejo-González, Ana-EstefanÃa Gutiérrez-Carrillo, Adriana-Inés RodrÃguez-Hernández, Ma. del RocÃo López-Cuellar & Norberto ChavarrÃa-HernándezÂ
doi : 10.1007/s12602-021-09825-0
A survey is presented concerning original research articles published in well-reputed scientific journals on the isolation of lactic acid bacteria (LAB) from cheeses worldwide, where researchers evaluated the bacteriocin production by such isolates in searching for novel functional peptides that can exhibit potential for biotechnological applications.
Mingkui Lv, Sifan Wang, Huajuan Yin, Kun Dong, Yiqiu Liu, Hongbin Pan, Qiuye Lin & Zhenhui CaoÂ
doi : 10.1007/s12602-022-09935-3
This study aimed to investigate the probiotic potential of gut indigenous lactic acid bacteria (LAB) originated from Apis cerana. Six Limosilactobacillus reuteri and one Lactobacillus helveticus were isolated from gut samples of A.
Soumya Basu, Sahil Mandar Joshi, Sudha Ramaiah & Anand AnbarasuÂ
doi : 10.1007/s12602-022-09929-1
Anti-microbial resistance (AMR) creating healthcare concerns worldwide requires ardent exploration of therapeutic alternatives. Although anti-microbial peptides (AMP) are popular for broad-spectrum activity, recent evidence of increasing resistance to membrane-acting AMPs by ESKAPE pathogens has compelled us to design novel AMPs as therapeutic candidates.
A. Panigrahi, P. Esakkiraj, C. Saranya, R. R. Das, M. Sundaram, N. S. Sudheer, I. F. Biju & M. JayanthiÂ
doi : 10.1007/s12602-022-09926-4
Experiments were conducted to evaluate the probiotic effect of bio-augmented Bacillus tequilensis AP BFT3 on improving production, immune response, and proteomic changes of Penaeus vannamei reared in a biofloc system.
Ghazal Aziz, Arsalan Zaidi & Muhammad TariqÂ
doi : 10.1007/s12602-022-09931-7
The local pharmacies and shops are brimming with various probiotic products that herald a range of health benefits.
Luiz F. F. Oliveira, Giselle Aparecida da Silva, Pedro H. F. Silva, André Luis Gomes Moreira, Sérgio L. Salvador, Adriano Gomes da Cruz, Michel R. Messora & Flávia A. C. FurlanetoÂ
doi : 10.1007/s12602-022-09930-8
This study aimed to assess the effects of the probiotic (PROB) Bifidobacterium animalis subsp. lactis HN019 in two different delivery vehicles in experimental periodontitis (EP), including the gene expression for IL-10, IFN-γ, and FOXP3.
Sima Sadat Seyedjavadi, Mehdi Razzaghi-Abyaneh, Mohammad Javad Nasiri, Ali Hashemi, Hossein Goudarzi, Mehrdad Haghighi, Masoud Dadashi, Mehdi Goudarzi, Hadi Zare-Zardini & Behzad PourhosseinÂ
doi : 10.1007/s12602-022-09907-7
Today, resistance of microorganisms to antibiotics has become a major challenge. To overcome this problem, development of new drugs, besides research on their antibacterial activity, is essential.
Lei Tian, Rongmei Liu, Zhiwei Zhou, Xiaofang Xu, Su Feng, Ariel Kushmaro, Robert S. Marks, Dan Wang & Qun SunÂ
doi : 10.1007/s12602-021-09886-1
In this study, the probiotic potential and treatment effects of Lactiplantibacillus plantarum N-1 in hypercholesterolemic rats were investigated, and the possible regulatory mechanisms of lipid metabolism via short-chain fatty acids (SCFAs) and 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase were elucidated.
Georgianna de Araújo Henriques Ferreira, Marciane Magnani, Lucélia Cabral, Larissa Ramalho Brandão, Melline Fontes Noronha, Josiane de Campos Cruz, Evandro Leite de Souza & José Luiz de Brito AlvesÂ
doi : 10.1007/s12602-021-09889-y
High-fat diet (HFD) consumption is a risk factor for dyslipidemias, insulin resistance, and arterial hypertension linked with gut dysbiosis. Probiotic administration has been suggested as a safe therapeutic strategy for gut microbiota modulation and treatment and/or prevention of cardiometabolic disorders.
Shalaka Bhawal, Ankita Kumari, Suman Kapila & Rajeev KapilaÂ
doi : 10.1007/s12602-021-09891-4
The probiotic extracellular matrix components (ECM) have been considered as an important factor in eliciting the beneficial roles of the bacteria. The study involved the growth phase–dependent extraction of the surface layer protein (SLP) and cell-bound exopolysaccharide (EPS-b) from novel Limosilactobacillus fermentum (MTCC 5898). Both SLP and EPS-b were optimally extracted at the late logarithmic phase of the bacteria upon 8 h of incubation.
Darong Huang, Yanlan Chen, Hongzhu Chen, Xinyu Deng, Jianzhao Huang, Siming Lu, Pan Li & Bing DuÂ
doi : 10.1007/s12602-022-09906-8
Bacillus sp. DU-106, a potential probiotic, has been proved to activate innate immunity, reduce hypercholesterolemia, and regulate the gut microbiota of mice. In the present study, we investigated the therapeutic effect of strain DU-106 in antibiotic-associated diarrhea (AAD) via analyzing the changes in gut microbial composition in mice.
P. Hasslöf, L. Granqvist, C. Stecksén-Blicks & S. TwetmanÂ
doi : 10.1007/s12602-022-09913-9
The aim of this study was to evaluate the effect of drops containing probiotic bacteria on the recurrence of dental caries in preschool children. The study employed a randomized, placebo-controlled, double-blinded design with two parallel arms.
Rukesh Maharjan, Arif Iftikhar Khan, Muhammad Nadeem-ul-Haque, Marc Maresca, M. Iqbal Choudhary, Farzana Shaheen & Shabana U. SimjeeÂ
doi : 10.1007/s12602-022-09915-7
Anti-microbial peptides (AMPs) have attracted major attention due to their potential bio-activities against some multidrug resistant pathogens. The present study evaluated the mechanism of actions of highly potent AMP temporin-SHa analogs, i.e., [G4a]-SHa, [G7a]-SHa, and [G10a]-SHa, against methicillin-resistant Staphylococcus aureus (MRSA) NCTC (13277) with minimum inhibitory concentrations (MICs) of 14.35, 7.16, and 3.58 µM, respectively.
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟